Click here to download the catalog as a PDF file.
iPaper - Page 3
HOT TOPICS Neisseria gonorrhoeae: Is Resistance a Concern in 2012? Although the incidence of N. gonorrhoeae has not increased in recent years, it continues to be a significant cause of sexually transmitted infections in the US and the world. In most laboratories, testing has been converted from culture to molecular methods, and consequently, susceptibility testing is not performed routinely. Through the efforts of the Gonococcal Infection Surveillance Program (GISP) and other groups, data is available about the present state of the art in regard to gonococcal antimicrobial resistance. Results of this data will be described in the context of the epidemiology of Neisseria gonorrhoeae today. Available until 7/17/2012 • $105 Archived Webinar CLSI 2012 AST Update Each January, CLSI updates standards for antimicrobial susceptibility testing (AST). It is important for clinical laboratories to incorporate the new recommendations into routine practice to optimize detection and reporting of antimicrobial resistance. In January 2012, the annual update of the M100 tables (CLSI document M100-S22) will be published along with updates of the standards that describe how to perform disk diffusion (M02-A11) and MIC tests (M07-A9). One of the highlights for 2012 will be revised interpretive criteria (breakpoints) for betalactams and Pseudomonas aeruginosa. These breakpoint changes and several other new recommendations found in M02-A11, M07-A9 and M100-S22 will be discussed. Available until 8/1/2012 • $95 APHL–CLSI Archived Webinar P C (588-900-12) P C V (588-601/602-12) Non-O157 Shiga Toxin-producing E. coli: It’s a New World Out There Despite incomplete knowledge of the distribution of non-O157 STEC and their role in disease, several recent outbreaks involving these agents illustrate their potential to cause widespread, serious disease. This presentation will review the evidence for the pathogenic significance of non-O157 STEC, discuss the CDC recommendations for clinical laboratories to include testing for all STEC in every routine stool culture, and describe testing protocols to demonstrate STEC. Available until 7/31/2012 • $105 Archived Webinar What a great teleconference! P C (588-902-12) www.LaboratoryTraining.org 3